This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hanson, M. S.
Right arrow Articles by Ulbrandt, N. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hanson, M. S.
Right arrow Articles by Ulbrandt, N. D.

 Previous Article  |  Next Article 

Infection and Immunity, November 2000, p. 6457-6460, Vol. 68, No. 11
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Evidence for Vaccine Synergy between Borrelia burgdorferi Decorin Binding Protein A and Outer Surface Protein A in the Mouse Model of Lyme Borreliosis

Mark S. Hanson,* Nita K. Patel, David R. Cassatt, and Nancy D. Ulbrandt

MedImmune, Inc., Gaithersburg, Maryland 20878

Received 14 April 2000/Returned for modification 12 June 2000/Accepted 24 August 2000

Mice immunized with either the predominantly vector-stage lipoprotein outer surface protein A (OspA) or the in vivo-expressed lipoprotein decorin binding protein A (DbpA) are protected against Borrelia burgdorferi challenge. DbpA-OspA combinations protected against 100-fold-higher challenge doses than did either single-antigen vaccine and conferred significant protection against heterologous B. burgdorferi, B. garinii, and B. afzelii isolates, suggesting that there is synergy between these two immunogens.


* Corresponding author. Mailing address: MedImmune, Inc., 35 W. Watkins Mill Rd., Gaithersburg, MD 20878. Phone: (301) 527-4264. Fax: (301) 527-4200. E-mail: hansonm{at}medimmune.com.


Infection and Immunity, November 2000, p. 6457-6460, Vol. 68, No. 11
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Barthold, S. W., Hodzic, E., Tunev, S., Feng, S. (2006). Antibody-mediated disease remission in the mouse model of lyme borreliosis.. Infect. Immun. 74: 4817-4825 [Abstract] [Full Text]  
  • Kim, J. H., Singvall, J., Schwarz-Linek, U., Johnson, B. J. B., Potts, J. R., Hook, M. (2004). BBK32, a Fibronectin Binding MSCRAMM from Borrelia burgdorferi, Contains a Disordered Region That Undergoes a Conformational Change on Ligand Binding. J. Biol. Chem. 279: 41706-41714 [Abstract] [Full Text]  
  • Willett, T. A., Meyer, A. L., Brown, E. L., Huber, B. T. (2004). An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitope. Proc. Natl. Acad. Sci. USA 101: 1303-1308 [Abstract] [Full Text]  
  • Feng, S., Hodzic, E., Freet, K., Barthold, S. W. (2003). Immunogenicity of Borrelia burgdorferi Arthritis-Related Protein. Infect. Immun. 71: 7211-7214 [Abstract] [Full Text]  
  • Liang, F. T., Nelson, F. K., Fikrig, E. (2002). Molecular Adaptation of Borrelia burgdorferi in the Murine Host. JEM 196: 275-280 [Abstract] [Full Text]  
  • Heikkila, T., Seppala, I., Saxen, H., Panelius, J., Yrjanainen, H., Lahdenne, P. (2002). Species-Specific Serodiagnosis of Lyme Arthritis and Neuroborreliosis Due to Borrelia burgdorferi Sensu Stricto, B. afzelii, and B. garinii by Using Decorin Binding Protein A. J. Clin. Microbiol. 40: 453-460 [Abstract] [Full Text]  
  • Ulbrandt, N. D., Cassatt, D. R., Patel, N. K., Roberts, W. C., Bachy, C. M., Fazenbaker, C. A., Hanson, M. S. (2001). Conformational Nature of the Borrelia burgdorferi Decorin Binding Protein A Epitopes That Elicit Protective Antibodies. Infect. Immun. 69: 4799-4807 [Abstract] [Full Text]